Does the assessment of rare and common genetic variants improve hypertrophic cardiomyopathy risk prediction beyond clinical factors in the general population?
Incorporating rare and common genetic variants improves the prediction of hypertrophic cardiomyopathy risk beyond standard clinical factors.
Both rare and common genetic variants contribute substantially to HCM susceptibility in the general population and improve HCM risk prediction beyond that achieved with clinical factors.
Biddinger et al. (Wed,) studied this question.